Back
Range Oncology Therapeutics ETF Vs. Inhibrx(DELISTED) Industry Stock Comparison
Sell
38
CNCR
Range Oncology Therapeutics ETF
Last Price:
13.94
Seasonality Move:
2.37%
Sell
41
INBX:DL
Inhibrx(DELISTED)
Last Price:
30.63
Seasonality Move:
49.29%
Sell
38
Range Oncology Therapeutics ETF (CNCR)
is a Sell
Is Range Oncology Therapeutics ETF a Buy, Sell or Hold?
- The current Range Oncology Therapeutics ETF [CNCR] share price is $13.88. The Score for CNCR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Inhibrx(DELISTED) (INBX:DL)
is a Sell
Is Inhibrx(DELISTED) a Buy, Sell or Hold?
- The current Inhibrx(DELISTED) [INBX:DL] share price is $30.63. The Score for INBX:DL is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- INBX:DL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CNCR Stock Price Chart
What is Range Oncology Therapeutics ETF's stock price today?
-
The Range Oncology Therapeutics ETF share price today is $13.88
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing selling pressure, which indicates risk of future bearish movement.
INBX:DL Stock Price Chart
What is Inhibrx(DELISTED)'s stock price today?
-
The Inhibrx(DELISTED) share price today is $30.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INBX:DL is experiencing slight buying pressure.
CNCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 36.81 | Sell |
Chaikin Money Flow: | -6575 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.36 - 15.04) | Sell |
Bollinger Bands (100): | (14.47 - 16.39) | Sell |
INBX:DL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.37 | Sell |
Relative Strength Index (14 RSI): | 18.16 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.39 - 34.87) | Sell |
Bollinger Bands (100): | (33.91 - 37.15) | Sell |
CNCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.49 | Sell |
20-day SMA: | 14.59 | Sell |
50-day SMA: | 14.87 | Sell |
200-day SMA: | 13.46 | Buy |
8-day EMA: | 14.41 | Sell |
20-day EMA: | 14.6 | Sell |
50-day EMA: | 14.88 | Sell |
200-day EMA: | 14.25 | Sell |
INBX:DL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.82 | Sell |
20-day SMA: | 34.13 | Sell |
50-day SMA: | 34.45 | Sell |
200-day SMA: | 28.52 | Buy |
8-day EMA: | 33.46 | Sell |
20-day EMA: | 33.98 | Sell |
50-day EMA: | 34.35 | Sell |
200-day EMA: | 30.69 | Sell |
Range Oncology Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Inhibrx(DELISTED) Earnings Growth & INBX:DL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Range Oncology Therapeutics ETF Technical Analysis
Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Inhibrx(DELISTED) Technical Analysis
May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|
May | ||||||||
20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||
8-day SMA: | ||||||||
20-day SMA: | ||||||||
50-day SMA: | ||||||||
200-day SMA: | ||||||||
8-day EMA: | ||||||||
20-day EMA: | ||||||||
50-day EMA: | ||||||||
200-day EMA: | ||||||||
MACD (12, 26): | ||||||||
Relative Strength Index (14 RSI): | ||||||||
Bollinger Bands (25): | ||||||||
Bollinger Bands (100): |